Founder
David Pope
David Pope is a commercial and operational executive with more than 15 years of leadership experience spanning healthcare, medical technology, energy, and publicly traded companies. Throughout his career, he has focused on transforming complex technologies into scalable commercial platforms while aligning operations, sales, engineering, and finance to drive growth and improve performance.
David began his career in medical technology with Erchonia Medical, supporting international expansion initiatives across Europe, Asia, and the Middle East and contributing to product commercialization and physician adoption strategies. He also gained experience within the musculoskeletal device sector through Lone Star Extremities, whose technology platform was later acquired by Wright Medical and integrated into Stryker.
He later held senior leadership positions with publicly traded companies including ORBCOMM and Newpark Resources. At Newpark, he helped lead commercial and operational initiatives across North America, contributing to a business transformation supporting more than $265 million in revenue while managing large cross-functional teams. At ORBCOMM, he led growth initiatives within the energy sector, securing enterprise agreements and developing scalable commercial strategies.
As the Founder of Erythraxis, David brings a unique combination of healthcare, commercialization, and operational leadership experience. His background in building organizations, developing growth strategies, and bringing innovative technologies to market supports Erythraxis' mission to address unmet needs in testosterone replacement therapy-induced erythrocytosis.
David holds an MBA and a Bachelor of Science in Healthcare Sciences from Boise State University.